CELLAVISION AB (publ) Interim report for the period January 1-June 30, 2010
Increased sales growth for the first six months of 2010
January-June 2010
* Net sales amounted to SEK 57.8 million (42.7), an increase of 35 %
* The operating result amounted to SEK 2.7 million (1.8)
* The result after taxation amounted to SEK 3.4 million (1.4)
* The result per share amounted to SEK 0.14 (0.06)
* Cash and cash equivalents amounted to SEK 25.1 million (9.3) at the end of
the period
* CellaVision strengthens its distribution network by entering an agreement
with Beckman Coulter and by expanding collaboration with Sysmex
April-June 2010
* Net sales increased to SEK 36.6 million (20.7), an increase of 77 %
* Operating result amounted to SEK 7.1 million (1.0)
* The result after taxation amounted to SEK 8.1 million (0.9)
* The result per share amounted to SEK 0.34 (0.04)
* CellaVision was listed at the NASDAQ OMX Stockholm on May 31, 2010
CellaVision in short
April-June April-June Jan-June Jan-June Full
 (MSEK) 2010 2009 2010 2009 year
  2009
 Net sales 36.6 20.7 57.8 42.7 109.0
 Gross profit 26.8 16.8 40.8 30.9 76.5
 Operating 7.1 1.0
result 2.7 1.8 14.8
 Result before 8.0 0.9
tax 3.4 1.4 14.2
 Cash flow 7.1 -5.1 3.1 -10.3 2.3
CEO's comment
"CellaVision shows strong growth in the first six month of 2010. Sales were
close to SEK 58 million, which is an increase of 35 % compared to the same
period last year. In the second quarter we regained the drop in sales and
results in the first quarter, mostly because the Sysmex sales of the CellaVision
DM1200 in Europe are gaining momentum. Markets outside Europe and North America
comprise 10%, indicating that we are now beginning to see results from our
efforts in countries such as Japan and China." says Yvonne MÃ¥rtensson, CEO of
CellaVision.
"We have now distribution agreements with Sysmex and Beckman Coulter in place
and look forward to rewarding collaborations ahead. We are confident in our new
distribution strategy, which allows us to further penetrate several of our most
important markets such as the US and Japan. With both strong sales channels and
a new analyzer in our product line, we are increasing our chances for a
continuing successful strategic expansion and growth in 2010."
"CellaVision was listed on Nasdaq OMX Stockholm at the end of May, an important
event in the history of our company. The listing gives us more freedom in our
continued expansion and invites institutions to invest in CellaVision."
For more information please contact:
Yvonne MÃ¥rtensson, CEO. Phone: +46 708 33 77 82,
e-mail:yvonne.martensson@cellavision.com
Johan Wennerholm, CFO. Phone: +46 708 33 81 68,
e-mail:johan.wennerholm@cellavision.com
Download the report by pressing the link below.
[HUG#1431987]
CELLAVISION AB (publ) Interim report for the period January 1-June 30, 2010: http://hugin.info/132164/R/1431987/378374.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: CellaVision AB via Thomson Reuters ONE
